Open AccessThe Impact of Changing from Prednisolone to Dexamethasone for the Management of Wheeze in Children- A Service Evaluation
Author(s) -
James thyng,
Lynn Cunningham,
Susanne McKinley,
Felix Hay,
Catherine Nunn,
Damian Roland
Publication year - 2021
Publication title -
journal of advances in medicine and medical research
Language(s) - English
Resource type - Journals
ISSN - 2456-8899
DOI - 10.9734/jammr/2021/v33i1230941
Subject(s) - prednisolone , wheeze , dexamethasone , attendance , tolerability , medicine , emergency department , asthma , pediatrics , psychiatry , adverse effect , political science , law
Dexamethasone has become a popular alternative to Prednisolone as an oral steroid used for wheeze in children in many Paediatric Emergency Departments. It has proved non-inferior to Prednisolone in several studies [1,2] and its main advantages are single dose requirement and greater tolerability in children [3,4]. However, to the best of our knowledge there are no studies looking into the differences in re-attendance rates. Using our local Electronic Health Records, we extracted data of all over 5-year olds presenting with asthma and wheeze for 21 months of Prednisolone data and 15 months of Dexamethasone and found no statistically significant increase in re-attendance rates.